Lorglumide Properties, Molecular Formula, Applications - WorldOfChemicals

Lorglumide Properties


Molecule Structure Image



Lorglumide is a drug which inhibits gastrointestinal motility and reduces gastric secretions, acting as a cholecystokinin antagonist, with fairly high selectivity for the CCKA subtype. It has been suggested as a potential treatment for a variety of gastrointestinal problems including stomach ulcers, irritable bowel syndrome, dyspepsia, constipation and pancreatitis, as well as some forms of cancer, but animal and human testing has produced inconsistent results and no clear therapeutic role has been established, although it is widely used in scientific research.

Chemical Properties

CAS Number 97964-56-2
Density 1.195g/cm3
IUPAC Name N2-(3,4-Dichlorobenzoyl-N,N-dipentyl-α-glutamine
InChI 1S/C22H32Cl2N2O4/c1-3-5-7-13-26(14-8-6-4-2)22(30)19(11-12-20(27)28)25-21(29)16-9-10-17(23)18(24)15-16/h9-10,15,19H,3-8,11-14H2,1-2H3,(H,25,29)(H,27,28)
Molar Mass 459.406 g/mol
Molecular Formula C22H32Cl2N2O4
RTECS Number SA3680700
Synonyms Pentanoic acid,4-[(3,4-dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxo-;CR-1409;DL-4-(3,4-Dichlorobenzoylamino)-5-(dipentylamino)-5-oxopentanoic Acid;Lorglumide